Farmacy

Sep 18 2018

Joint Pharmaceutical Analysis Group, pharmaceutical analysis.#Pharmaceutical #analysis

pharmaceutical analysis

Pharmaceutical analysis

Pharmaceutical analysis

run for pharmaceutical analysts by pharmaceutical analysts

NEXT EVENT: Thursday 7th December 2017 – Ensuring amorphous product quality: what are the challenges. Pharmaceutical analysis

  • Pharmaceutical analysis
  • Pharmaceutical analysis
  • Pharmaceutical analysis
  • Pharmaceutical analysis
  • Pharmaceutical analysis
  • Pharmaceutical analysis
  • Pharmaceutical analysis

JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.

Ensuring amorphous product quality: what are the challenges?

Royal Society of Chemistry, London

Amorphous drug formulation offers great promise in improving drug solubility – a major challenge in drug development. However, poor physical stability and hard to predict crystallisation remains key barriers for the wider use of amorphous solid solution in the pharmaceutical industry.

Leading industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of amorphous products.

New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.

You may form new collaborations with experts across academic and industry.

Prof Gavin Andrews – Queen’s University Belfast

Prof Duncan Craig – University College London

Dr Korbinian Löbmann – University of Copenhagen

Dr Claire Pizzey – Diamond Light Source

Hans Platteeuw – Avivia

Dr Paul Royall – King’s College London

Dr Abhishek Singh – Johnson & Johnson

Dr Krzysztof Sollohub – Catalent

Royal Society of Chemistry, London

Continuing our successful continuing programme of pharmaceutical analysis symposia, this meeting will focus on cleaning validation and is aimed at providing the latest regulatory expectations and best practice information in the domain of cleaning validation since the publication of the European Medicines Agency Shared Facilities Guideline and subsequent Q uptake by Industry has been very slow.

This symposium, held in partnership with the Royal Pharmaceutical Society, will critically examine some of the challenges and opportunities that arise from adopting continuous manufacturing. Leading regulators, industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of continuous manufacturing.

Annual General Meeting

Royal Society of Chemistry, London

This is a closed meeting for members of JPAG

It is not necessary to register for the symposium to attend the AGM

Starts at 9.30 am

The pharmaceutical analysis postgraduate research awards and careers symposium

Royal Society of Chemistry, London

Pharmaceutical analysisJPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best podium and poster presentations will be recognised with cash prizes up to 500 GBP.

Pharmaceutical analysis

» Professor Melissa Hanna-Brown

Prof Hanna-Brown is Technology & Innovation EU Lead, Pfizer Worldwide R Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF) .Formerly he was Director of Allergan Inc (USA) and R going away with plenty of notes and specific items for discussion.

The prize for the best podium presentation at the pharmaceutical analysis postgraduate research awards & careers symposium held at the Royal Society of Chemistry on Tuesday 28th November has been announced.

The winner was Matthew C Hulme Manc.

Wednesday 29th November 2017

Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled “Design, formulation and manufacture of film-coated drug products”, written by Dr Dave Elder, Past-Chairman of the JPAG Commit.

Friday 3rd November 2017

Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled “Modernising the supply chain using continuous manufacturing”, co-written by Dr Dave Elder, Past-Chairman of the JPAG Committe.

Friday 3rd November 2017

COOKIES AND PERSONAL DATA:

This site does not use cookies.

However, it does securely hold details for those who register an account.

This information is only used by JPAG as described in the Privacy Statement (see link on footer below).





Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *